Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Goodwill (2016 - 2021)

Abeona Therapeutics has reported Goodwill over the past 7 years, most recently at $32.5 million for Q3 2021.

  • Quarterly results put Goodwill at $32.5 million for Q3 2021, changed 0.0% from a year ago — trailing twelve months through Sep 2021 was $32.5 million (changed 0.0% YoY), and the annual figure for FY2020 was $32.5 million, changed.
  • Goodwill for Q3 2021 was $32.5 million at Abeona Therapeutics, roughly flat from $32.5 million in the prior quarter.
  • Over the last five years, Goodwill for ABEO hit a ceiling of $32.5 million in Q1 2017 and a floor of $32.5 million in Q1 2017.
  • Median Goodwill over the past 5 years was $32.5 million (2017), compared with a mean of $32.5 million.
  • Peak annual rise in Goodwill hit 0.0% in 2017, while the deepest fall reached 0.0% in 2017.
  • Abeona Therapeutics' Goodwill stood at $32.5 million in 2017, then changed by 0.0% to $32.5 million in 2018, then changed by 0.0% to $32.5 million in 2019, then changed by 0.0% to $32.5 million in 2020, then changed by 0.0% to $32.5 million in 2021.
  • The last three reported values for Goodwill were $32.5 million (Q3 2021), $32.5 million (Q2 2021), and $32.5 million (Q1 2021) per Business Quant data.